FORM 8-K

Company

Inhibikase Therapeutics, Inc.

Filed

September 8, 2021

Period of Report

September 1, 2021

Accession Number

0001104659-21-113776

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →